- Home
- LFVN
as of 03-10-2026 3:58pm EST
$5.18
+$0.09
+1.77%
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
| Founded: | N/A | Country: | United States |
| Employees: | N/A | City: | LEHI |
| Market Cap: | 62.0M | IPO Year: | 1996 |
| Target Price: | N/A | AVG Volume (30 days): | 165.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | semi-annual | |
| EPS: | 0.19 | EPS Growth: | 226.09 |
| 52 Week Low/High: | $3.90 - $17.64 | Next Earning Date: | N/A |
| Revenue: | $203,204,000 | Revenue Growth: | 1.86% |
| Revenue Growth (this year): | -13.93% | Revenue Growth (next year): | -0.94% |
| P/E Ratio: | 25.68 | Index: | N/A |
| Free Cash Flow: | 10.5M | FCF Growth: | -86.84% |
Stock Insider Trading Activity of Lifevantage Corporation (Delaware) (LFVN)
Dayton Judd
Buy
Director
LFVN Mar 2, 2026
Avg Cost/Share
$4.53
Shares
10,500
Total Value
$47,565.00
Owned After
80,359
SEC Form 4
Dayton Judd
Buy
Director
LFVN Feb 27, 2026
Avg Cost/Share
$4.63
Shares
18,097
Total Value
$83,789.11
Owned After
80,359
SEC Form 4
Dayton Judd
Buy
Director
LFVN Feb 26, 2026
Avg Cost/Share
$4.58
Shares
4,600
Total Value
$21,068.00
Owned After
80,359
SEC Form 4
Lewis Darwin
Buy
Director
LFVN Feb 9, 2026
Avg Cost/Share
$5.22
Shares
3,955
Total Value
$20,651.43
Owned After
135,508
SEC Form 4
Lewis Darwin
Buy
Director
LFVN Dec 15, 2025
Avg Cost/Share
$6.54
Shares
805
Total Value
$5,264.62
Owned After
135,508
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Dayton Judd | LFVN | Director | Mar 2, 2026 | Buy | $4.53 | 10,500 | $47,565.00 | 80,359 | |
| Dayton Judd | LFVN | Director | Feb 27, 2026 | Buy | $4.63 | 18,097 | $83,789.11 | 80,359 | |
| Dayton Judd | LFVN | Director | Feb 26, 2026 | Buy | $4.58 | 4,600 | $21,068.00 | 80,359 | |
| Lewis Darwin | LFVN | Director | Feb 9, 2026 | Buy | $5.22 | 3,955 | $20,651.43 | 135,508 | |
| Lewis Darwin | LFVN | Director | Dec 15, 2025 | Buy | $6.54 | 805 | $5,264.62 | 135,508 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K BUY Feb 4, 2026 · 100% conf.
2025
Q4
Q4 2025 Earnings
8-K BUYFeb 4, 2026 · 100% conf.
AI Prediction BUY
1D
+1.11%
$5.61
5D
+12.96%
$6.27
20D
+21.38%
$6.74
Price: $5.55 Prob +5D: 100% AUC: 1.000
0001628280-26-005431
lfvn-202601300000849146false00008491462026-01-302026-01-30
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 30, 2026
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3564790-0224471 (State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)
3300 Triumph Blvd, Suite 700 Lehi, Utah 84043 (Address of principal executive offices, including zip code) (801) 432-9000 (Registrant's telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On February 4, 2026, LifeVantage Corporation (the “Company”) issued a press release announcing its financial results for the three and six months ended December 31, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference. The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 30, 2026, Steven R. Fife notified the Company's board of directors (the “Board”) of his decision to retire as President and Chief Executive Officer and from the Board, with such resignation expected to be effective in April 2026. Mr. Fife’s decision to retire is not the result of any disagreement with the Company on any matter relating to the Company's operations, financial policies or practices. More information on Mr. Fife’s retirement can be found in the press release furnished as Exhibit 99.2 to this current report on Form 8-K and incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No.Description
99.1Press Release issued by the Company on February 4, 2026, announcing its financial results for the three and six months ended December 31, 2025.
99.2Press Release issued by the Company on February 4, 2026, announcing Mr. Fife's retirement.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:February 4, 2026By:LIFEVANTAGE CORPORATION
/s/ Carl A. Aure Name:Carl A. Aure Title:Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Nov 4, 2025
2025
Q3
Q3 2025 Earnings
8-KNov 4, 2025
0001628280-25-048801
lfvn-202511040000849146false00008491462025-11-042025-11-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 4, 2025
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3564790-0224471 (State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)
3300 Triumph Blvd, Suite 700 Lehi, Utah 84043 (Address of principal executive offices, including zip code) (801) 432-9000 (Registrant's telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On November 4, 2025, the Company issued a press release announcing its financial results for the three months ended September 30, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference. The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No.Description
99.1Press Release issued by the Company on November 4, 2025, announcing its financial results for the three months ended September 30, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date:November 4, 2025By:LIFEVANTAGE CORPORATION
/s/ Carl A. Aure Name:Carl A. Aure Title:Chief Financial Officer
2025 Q2 Q2 2025 Earnings
8-K Sep 4, 2025
2025
Q2
Q2 2025 Earnings
8-KSep 4, 2025
0000849146-25-000069
lfvn-202509040000849146false00008491462025-09-042025-09-04
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 4, 2025
LIFEVANTAGE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware001-3564790-0224471 (State or other jurisdiction of incorporation or organization)(Commission File Number)(IRS Employer Identification No.)
3300 Triumph Blvd, Suite 700 Lehi, Utah 84043 (Address of principal executive offices, including zip code) (801) 432-9000 (Registrant's telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Common Stock, par value $0.0001LFVNThe Nasdaq Stock Market LLC Title of each classTrading Symbol(s)Name of each exchange on which registered
Indicate by check mark whether the Registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02. Results of Operations and Financial Condition. On September 4, 2025, LifeVantage Corporation (the “Company”) issued a press release announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2025. A copy of the Company’s press release is attached as Exhibit 99.1 to this report and incorporated by reference. The information furnished in this Item 2.02 and the exhibit hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing. Item 9.01. Financial Statements and Exhibits. (d) Exhibits
Exhibit No. Description
99.1Press Release issued by the Company on September 4, 2025, announcing its financial results for the fourth quarter and full fiscal year ended June 30, 2025.
104Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: September 4, 2025LIFEVANTAGE CORPORATION
By: /s/ Carl A. Aure Name: Carl A. Aure Title: Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)
Latest Lifevantage Corporation (Delaware) News
LFVN Breaking Stock News: Dive into LFVN Ticker-Specific Updates for Smart Investing
Compare LFVN vs Leading Stocks
See how LFVN stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "LFVN Lifevantage Corporation (Delaware) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.